Master Clinical Sciences
for MRCP Part 1

What the MRCP Part 1 Tests in Clinical Sciences

Clinical Sciences on MRCP Part 1 tests the application of pathophysiology, pharmacology, and epidemiology to common and important clinical presentations. Candidates must interpret symptoms, signs, and basic investigations (e.g., ECG, chest X-ray, routine bloods) to identify likely diagnoses, select first-line treatments, and recognise red flags. Questions often focus on evidence-based management per NICE, SIGN, or BTS guidelines, including drug choices, doses, and contraindications. Key areas include acute coronary syndromes, heart failure, asthma/COPD, diabetes, stroke, infections (e.g., community-acquired pneumonia, meningitis), and rheumatological conditions. Candidates must know diagnostic criteria (e.g., for SLE, rheumatoid arthritis, cirrhosis), screening thresholds (e.g., HbA1c ≥48 mmol/mol for diabetes), and emergency protocols (e.g., anaphylaxis, sepsis).

High-Yield Concepts

• Acute Coronary Syndrome (ACS) Management: For STEMI, primary PCI within 120 minutes; if >120 minutes, give fibrinolysis (tenecteplase). Dual antiplatelet therapy: aspirin 300 mg loading then 75 mg OD, plus ticagrelor 180 mg loading then 90 mg BD (or prasugrel 60 mg loading then 10 mg OD). Unfractionated heparin or enoxaparin (1 mg/kg BD) as anticoagulant. Beta-blocker (e.g., bisoprolol 2.5-10 mg OD) within 24 hours if no contraindication.
• Heart Failure with Reduced Ejection Fraction (HFrEF): First-line: ACE inhibitor (e.g., ramipril 2.5-10 mg OD) plus beta-blocker (e.g., bisoprolol 1.25-10 mg OD). If still symptomatic, add mineralocorticoid receptor antagonist (e.g., spironolactone 25-50 mg OD). Consider ARNI (sacubitril/valsartan) as alternative to ACE inhibitor. Loop diuretic (e.g., furosemide 40 mg OD) for fluid overload. LVEF ≤40% defines HFrEF.
• Community-Acquired Pneumonia (CAP) Severity and Treatment: Use CURB-65 score: Confusion (AMT≤8), Urea >7 mmol/L, Respiratory rate ≥30/min, BP systolic <90 or diastolic ≤60 mmHg, age ≥65. Score 0-1: oral amoxicillin 500 mg TDS for 5 days. Score 2: hospital admission; oral amoxicillin 500 mg TDS plus clarithromycin 500 mg BD. Score ≥3: IV co-amoxiclav 1.2 g TDS plus clarithromycin 500 mg BD.
• Type 2 Diabetes Diagnosis and First-Line Therapy: Diagnosis: fasting glucose ≥7.0 mmol/L, or HbA1c ≥48 mmol/mol (6.5%), or 2-hour glucose ≥11.1 mmol/L on OGTT. First-line metformin 500 mg BD, titrate to 1 g BD. If HbA1c rises despite metformin, add SGLT2 inhibitor (e.g., dapagliflozin 10 mg OD) or DPP-4 inhibitor (e.g., sitagliptin 100 mg OD) if eGFR adequate.
• Stroke and Transient Ischaemic Attack (TIA) Management: For acute ischaemic stroke within 4.5 hours, consider alteplase 0.9 mg/kg IV (max 90 mg) if no contraindications. For TIA or minor stroke, start aspirin 300 mg OD for 2 weeks, then clopidogrel 75 mg OD. Carotid endarterectomy if ipsilateral carotid stenosis >70% on Doppler. Blood pressure target <130/80 mmHg after acute phase.
• Anaphylaxis Acute Treatment: First-line: IM adrenaline 0.5 mg (0.5 mL of 1:1000) into anterolateral thigh, repeat every 5 minutes if no improvement. High-flow oxygen, IV fluids (crystalloid 500-1000 mL bolus). Chlorphenamine 10 mg IM/IV, and hydrocortisone 200 mg IM/IV as second-line. Monitor for biphasic reaction.
• Systemic Lupus Erythematosus (SLE) Diagnosis: Use SLICC criteria: need ≥4 criteria (at least 1 clinical and 1 immunologic) or biopsy-proven lupus nephritis with ANA or anti-dsDNA. Clinical: malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, serositis, renal (proteinuria >0.5 g/day), neurologic (seizures/psychosis), haematologic (haemolytic anaemia, leukopenia <4000, lymphopenia <1500, thrombocytopenia <100,000). Immunologic: ANA, anti-dsDNA, anti-Sm, antiphospholipid antibodies, low complement.
• Cirrhosis Diagnosis and Decompensation: Diagnosis: liver biopsy or combination of clinical signs (spider naevi, palmar erythema, caput medusae), imaging (nodular liver, splenomegaly), and labs (low albumin, elevated INR, platelets <150,000). Child-Pugh score classifies severity (A to C). Decompensation: ascites, variceal haemorrhage, hepatic encephalopathy, jaundice. First-line for ascites: sodium restriction and spironolactone 100-400 mg OD.

Common Traps in Clinical Sciences Questions

• Confusing CURB-65 with CRB-65 (CRB-65 omits urea, used in primary care).
• Using IV adrenaline for anaphylaxis when IM is first-line (IV risks arrhythmia).
• Starting aspirin 75 mg for acute stroke instead of 300 mg for first 2 weeks.
• Diagnosing diabetes based on HbA1c alone in pregnancy or renal failure (use OGTT).
• Forgetting to check eGFR before starting metformin (stop if <30 mL/min) or SGLT2 inhibitors (stop if <45 mL/min).
• Assuming all heart failure patients need digoxin (reserved for atrial fibrillation or refractory symptoms despite standard therapy).

How to Revise Clinical Sciences for the MRCP Part 1

Prioritise memorising guideline-based cut-offs and first-line drug doses (e.g., CURB-65, HbA1c thresholds, adrenaline dose). Questions often present a clinical vignette with subtle clues (e.g., age, comorbidities, vital signs) and ask for the next best management step or most likely diagnosis. Practise interpreting ECGs (STEMI criteria, atrial fibrillation, heart block) and chest X-rays (consolidation, effusion, pneumothorax). Focus on common presentations: chest pain, dyspnoea, fever, joint pain, altered consciousness. Review NICE and BTS summaries for CAP, ACS, stroke, and diabetes. Avoid spending time on rare diseases; the exam tests bread-and-butter medicine.

Practise it: MedLumen has 50 Clinical Sciences questions for the MRCP Part 1, each with a full explanation and references.